Business Wire

IFF’s Nicolas Mirzayantz Honored at Fragrance Foundation Circle of Champions

Jaa

Regulatory News:

This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171102006707/en/

Leonard A. Lauder (right) presents Nicolas Mirzayantz with the Fragrance Foundation’s Circle of Cham ...

Leonard A. Lauder (right) presents Nicolas Mirzayantz with the Fragrance Foundation’s Circle of Champions Award. (Photo: Business Wire)

International Flavors & Fragrances Inc. (NYSE: IFF) (Euronext Paris: IFF), a leading innovator of sensory experiences that move the world, is pleased to announce its Group President, Fragrances, Nicolas Mirzayantz, was honored at the Fragrance Foundation’s Circle of Champions event, held last night in New York City. The award recognizes individuals who have made notable contributions to the fragrance industry.

“For nearly thirty years, Nicolas has shared his passion for the industry, innovation, and sustainability, creating meaningful and lasting value for both IFF and our customers,” said IFF Chairman and CEO Andreas Fibig. “He exemplifies IFF at its best and it is fitting that he is honored by the very people whom he has long admired and from whom he has taken so much inspiration.”

"It was a fantastic celebration inducting Nicolas into The Fragrance Foundation's Circle of Champions," said Linda G. Levy, President of The Fragrance Foundation. "Nicolas is a true champion of the industry with a zest for life and creative passion for fragrance. His life of accomplishments deserves all the beautiful tributes shared by our friends and colleagues."

Mr. Mirzayantz began his working life with the French Embassy in Nicaragua as a Trade Attaché. Passionate about photography, he passed on an opportunity with National Geographic to join IFF’s Paris office in 1988 as sales support for its Italian affiliate. He quickly moved to an Account Executive role, first in Paris, then in the Company’s headquarters in New York, where he moved to roles of increasing responsibility. In 2006, he was named Group President, Fragrances, responsible for global strategy, commercial and creative execution, people development and profit and loss in the Fragrances Business Unit. In addition to his role as Group President, Mr. Mirzayantz serves as President of IFF’s prestigious unit of natural products, Laboratoire Monique Rémy in Grasse, France, considered the industry benchmark of naturals globally.

The event brought together family, friends, colleagues, customers, and mentors in a moving series of speeches and tributes by Jerry Vittoria, Chairman, The Fragrance Foundation and President, Fine Fragrances Worldwide, Firmenich; Linda G. Levy, President, The Fragrance Foundation; Andreas Fibig, IFF CEO; Carlos Benaim, IFF Master Perfumer; Ann Gottlieb, President, Ann Gottlieb Associates; and Leonard A. Lauder, Chairman Emeritus, The Estée Lauder Companies. The Master of Ceremonies was John Demsey, Executive Group President, The Estée Lauder Companies.

Mr. Mirzayantz accepted his award from Mr. Lauder and in his speech, commented, “In many businesses, we work in the shadows of our heroes. But in the beauty and fragrance industry, we walk among them every day. One of my life’s greatest joys is to have worked with so many icons and rising talents in this field for the last 30 years, a number of whom are here tonight. You ARE my mentors, colleagues, customers, competitors but most importantly, my friends.” Mr. Mirzayantz acknowledged the many people who have supported him through the years and called out the special role IFF played in his success -- “At IFF, we search for talent that looks at the world through a different lens and support them so that they can reach their full potential.”

# # #

Meet IFF

International Flavors & Fragrances Inc. (NYSE:IFF) (Euronext Paris: IFF) is a leading innovator of sensorial experiences that move the world. At the heart of our company, we are fueled by a sense of discovery, constantly asking “what if?”. That passion for exploration drives us to co-create unique products that consumers taste, smell, or feel in fine fragrances and beauty, detergents and household goods, as well as beloved foods and beverages. Our 7,400 team members globally take advantage of leading consumer insights, research and development, creative expertise, and customer intimacy to develop differentiated offerings for consumer products. Learn more at www.iff.com, Twitter , Facebook, Instagram, and LinkedIn.

Contact information

International Flavors & Fragrances Inc.
Michael DeVeau, 212.708.7164
VP, Corporate Strategy, Investor Relations & Communications
Michael.DeVeau@iff.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

ViiV Healthcare Shares Data from Landmark 2-Drug Regimen Trials At AIDS 201818.7.2018 20:21Tiedote

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, will be presenting over 20 abstracts, including data from the landmark GEMINI 1 & 2 clinical trials, at the 22nd International AIDS Conference (AIDS 2018), 23-27 July 2018, in Amsterdam, The Netherlands. The data being presented this year has a strong focus on novel exploratory therapeutic options and innovative treatment strategies, as well as improving awareness and understanding of key issues that continue to affect the HIV community. John C Pottage, Jr, MD, Chief Scientific and Medical Officer, ViiV Healthcare, commented, “As we see advancements in the treatment options available to people living with HIV, our research efforts over the past few years have been focused on moving beyond viral load and addressing some of the unresolved issues that people living with HIV face, such as the potential long-term risks and toxicities that can be associated with li

Xilam: H1 2018 Revenue: +50%18.7.2018 19:00Tiedote

Regulatory News: The Xilam Group (Paris:XIL) posted consolidated H1 2018 revenue of EUR 13,866 thousand, an increase of 50%. This increase represents an excellent performance, as it follows on the heels of growth of 54% in H1 2017. Revenue for the first part of this financial year breaks down as follows. In thousands of euros 30.06.2018 (1) 30.06.2017 Change New productions 8,465 4,571 +85% Catalogue 5,385 4,652 +16% Other 16 16 +0% Revenue and subsidies 13,866 9,239 +50% (1) Unaudited data. Remarkable success for new releases +85% Excellent H1 growth was driven by the two main businesses, New Productions and Catalogue. In New Productions, H1 deliveries generated record revenue of EUR 8,465 thousand, an 85% increase compared with H1 2017, and confirmed Xilam’s position as a major European animation company. Catalogue revenue was up 16% compared with H1 2017, thanks again to traditional TV channels and digital platforms, in both France and abroad. A fast-paced delivery schedule Thanks t

Department for International Trade: Life Sciences at the Heart of UK Economy18.7.2018 15:38Tiedote

The Government will today (Wednesday 18 July) host the second in a series of roundtables with stakeholders from key life science businesses, demonstrating the importance of the sector to the UK economy. The Chancellor, International Trade Secretary, Business Secretary and Health and Social Care Secretary will be amongst those that meet with senior representatives from leading UK and international life sciences companies as the UK positions itself as the global home of health innovation, welcoming overseas investment and seeking to boost exports in the process. Discussions at the roundtable will focus on how the future of the Life Sciences sector will be supported by the delivery of our modern Industrial Strategy, ensuring that the UK is ‘open for business’ with a positive business environment, our ambitions for a comprehensive agreement with the EU on our future relationship and the development and implementation of our independent trade policy. To date, the government has engaged sign

Universal Laser Systems Expands Its Materials Database with 3M, Victrex and Dexmet Materials18.7.2018 15:05Tiedote

Universal Laser Systems (ULS) announces the addition of 3M™, Victrex® and Dexmet materials to its materials database, the most extensive repository of laser material processing parameters for materials in the range of 10 watts to 500 watts. The 3M, Victrex and Dexmet materials new to the ULS materials database were specifically added for laser processing with the ULTRA and XLS platforms, suited for high accuracy and precision laser cutting, laser ablation and laser surface modification. The materials include: 3M™ Extreme Sealing Tape 4412N 3M™ Thermally Conductive Silicone Interface Pad 5516 Victrex® APTIV® PEEK Film Dexmet PolyGrid® 8PTFE10-125ST Expanded PTFE Dexmet MicroGrid® AL 25 Expanded Aluminum Laser processing notes, describing the results of the laser-material interaction for these materials, are also available in the Materials Library on the ULS website to help potential customers explore the advantages of deploying laser technology within their manufacturing, research and d

Sterigenics Expands European Capacity With New State-of-the-Art Gamma Sterilization Facility in the UK18.7.2018 15:00Tiedote

Sterigenics, a Sotera Health company and leading global provider of mission-critical sterilization solutions and expert advisory services, announced today it is building a new facility in Markham Vale North in Chesterfield/Derbyshire, UK. The facility will significantly expand Sterigenics’ footprint in Europe to help meet the growing sterilization needs of its customers and support the company’s mission of Safeguarding Global HealthTM. Scheduled for completion in the fourth quarter, 2018, the facility will include the installation of a state-of-the-art Nordion JS10000 gamma irradiator with a research loop. The new 60,000-square-foot facility will add gamma sterilization capabilities in the UK to complement Sterigenics’ existing ethylene oxide (EtO) facility based in Somercotes/Derbyshire. “Sterigenics is committed to being the world’s leading provider of sterilization services and partnering with our customers to eliminate threats to human health,” said Philip Macnabb, President of Ste

Smiths Detection Technology Chosen for Standard 3 Upgrade at Helsinki Airport18.7.2018 12:05Tiedote

Smiths Detection has been selected by Finnish airport operator, Finavia Corporation, to support the transition to Standard 3 at Helsinki Airport with approved hold baggage screening systems. Included in the contract are eight high-speed, HI-SCAN 10080 XCT scanners, which combine high resolution X-ray technology, computed tomography (CT) and advanced detection algorithms to increase both security and operational efficiency significantly. Security, speed and efficiency are critical to the extensive development programme underway at the airport, which will allow the airport to serve 30 million passengers annually and increase baggage handling capacity by 50%. “Any financial investment in upgrading security equipment has to be balanced against operational improvement, particularly when part of a major expansion. Airports need assurance that efficiencies will be gained and systems can be further updated as necessary to detect evolving explosive threats and handle ever higher volumes,” comme

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme